Tag: mechanical thrombectomy
Stroke community intensifies efforts to tackle “unacceptable” disparities in thrombectomy access
A wealth of new data confirming the beneficial role mechanical thrombectomy can play in the treatment of acute ischaemic stroke came to light through...
Direct thrombectomy fails to show non-inferiority versus bridging therapy in early...
The international DIRECT-SAFE trial has produced results indicating that intravenous thrombolysis (IVT) plus mechanical thrombectomy—commonly referred to as bridging therapy—should continue to be recommended...
Cerenovus reveals positive stent-retriever thrombectomy outcomes within EXCELLENT registry
Cerenovus, part of Johnson & Johnson MedTech, has today announced positive primary outcomes from the real-world EXCELLENT registry, focused on stroke-inducing blood clot removal...
World Stroke Congress bolsters evidence on optimal thrombectomy and thrombolysis approaches
While much-needed improvements to existing triage and transport protocols for acute stroke patients were a leading topic of focus on World Stroke Day (29...
BAOCHE trial results supporting thrombectomy for basilar artery stroke published in...
Results from the BAOCHE randomised controlled trial (RCT), which found that the addition of thrombectomy to standard medical care within 6–24 hours in basilar...
Physicians should prioritise first-pass optimisation over speed in thrombectomy procedures
Achieving clot retrieval with the fewest possible number of passes is critical in mechanical thrombectomy, and may even hold greater importance than how quickly...
New data demonstrate effectiveness of Penumbra system and RED catheters for...
Penumbra today announced initial INSIGHT registry data showing that its RED reperfusion catheters were successful in removing all clot types—and, additionally, results of sub-analyses...
Imperative Care announces positive, single-centre data on distal occlusion stroke treatment
Imperative Care recently announced that new data evaluating the utility of its Zoom stroke solution were presented at the 16th congress of the World...
SNIS 2022: COVID-19 may increase stroke risk in younger patients and...
Stroke patients with COVID-19 are facing worse outcomes, and are often younger and healthier, according to research presented recently at the Society of NeuroInterventional...
AI-powered device delivers “amazing physiologic information” to guide thrombectomy treatments
The Clotild smart guidewire system (Sensome), which uses artificial intelligence (AI) to provide real-time insights on clot composition, is showing early promise in the...
First Emboguard experiences reveal “excellent trackability and ease of use” in...
Having been launched earlier this year, the Emboguard balloon guide catheter (Cerenovus) was recently used in mechanical thrombectomy procedures for the first time. David...
AHA statement highlights need for more data on sex differences in...
A new American Heart Association (AHA) scientific statement has highlighted the need for more data about sex differences in the use of and response...
Women less likely to return to work after severe stroke, new...
According to new research published in Stroke, about one third of people who had a severe ischaemic stroke—and underwent a mechanical thrombectomy to remove...
Study data indicate positive outcomes with “exciting new treatment option” in...
Data from a multicentre clinical study supporting the use of Anaconda Biomed’s Advanced Neurovascular Access (ANA) catheter system for treating ischaemic stroke have been...
Children with severe stroke may fare better if treatment includes mechanical...
Serious disability is six times more likely to be the result three months after stroke among children whose large-vessel stroke was not treated with...
Newer clot-busting medication may someday increase time window for stroke treatment
In a phase 2a clinical trial in China, the clot-busting medication tenecteplase has been shown to be effective in restoring blood flow to the...
Cerenovus launches Emboguard balloon guide catheter for acute ischaemic stroke
Cerenovus—a neurovascular firm that forms part of Johnson & Johnson Medical Devices Companies—has announced the launch of Emboguard, its next-generation balloon guide catheter to...
Mechanical thrombectomy shown to restore more function than medication alone following...
A new study from Japan has become the first randomised controlled trial (RCT) to demonstrate the effectiveness of endovascular mechanical thrombectomy procedures in patients...
Reducing disability and death: What is next for stroke triage and...
Michael Chen (Rush University Medical Center, Chicago, USA) discusses the growing awareness around the need for timely interventions in stroke care in the USA,...
Enabling new possibilities in stroke treatment with Stream technology
This advertorial is sponsored by Perflow.
The StreamTM family of products (Perflow) is a range of dynamic neurothrombectomy net devices designed to give physicians greater...
Time savings, cost reductions and improved patient outcomes all key benefits...
Artificial intelligence (AI) and the role it can play in improving acute ischaemic stroke care protocols took centre stage at the Barts Research and...
AURORA: Evidence in favour of thrombectomy beyond six hours strengthened by...
Evidence favouring endovascular therapy (EVT) in anterior circulation stroke patients presenting with reversible cerebral ischaemia in the later time window (beyond six hours) from...
Hispanic stroke patients experience poorer post-thrombectomy outcomes than white counterparts
A study conducted by neurology researchers at University of Texas Southwestern (UTSW) Medical Center has found lower-quality functional outcomes for Hispanic ischaemic stroke patients...
Increased experience associated with shorter procedure times and better reperfusion rates...
Increasing levels of experience in performing mechanical thrombectomies have been associated with shorter procedural duration and better reperfusion rates in a multicentre study—with the...
World Stroke Day 2021: Get Ahead of Stroke campaign pushes for...
On World Stroke Day—29 October 2021—physicians from the Get Ahead of Stroke campaign are urging lawmakers to update triage and transport protocols. They are...
Phenox expands acute ischaemic stroke portfolio with global launch of pRESET...
Phenox has added to its extensive technology portfolio with the introduction of the pRESET 6-50 mechanical thrombectomy device for the treatment of acute large...
North Carolina updates stroke triage and transport protocol
North Carolina has updated its emergency stroke care protocol—a move applauded by the Get Ahead of Stroke campaign. The protocol, which went into effect...
NeuroVasc announces enrolment of first patient in ENVI-SR mechanical thrombectomy system...
NeuroVasc Technologies has announced that the first patient has been treated in a pivotal randomised controlled trial (RCT) in China, which will evaluate the...
Direct mechanical thrombectomy fails to show non-inferiority compared with IV t-PA...
The preliminary results of the SWIFT-DIRECT (Solitaire with the intention for thrombectomy plus IV t-PA versus direct Solitaire stent-retriever thrombectomy in acute anterior circulation...
Phenox highlights benefits of longer stentriever devices with new study results
Following its acceptance into Frontiers in Neurology, Phenox has announced the results of a paper exploring the benefit of choosing a longer stentriever for...
Repeated clot retrieval attempts linked to poorer functional outcome in acute...
Repeated clot retrieval attempts are associated with an increased rate of emboli to new territory (ENT) and greater infarct growth—resulting in poorer functional outcomes...
Sensome’s AI-powered stroke guidewire granted FDA Breakthrough Device designation
Sensome has announced its Clotild Smart Guidewire System—designed to improve the treatment of ischaemic stroke patients—has been granted a Breakthrough Device designation by the...
Noninferiority of thrombectomy alone further demonstrated in acute ischaemic stroke treatment
The noninferiority of mechanical thrombectomy alone—compared to mechanical thrombectomy plus intravenous tissue plasminogen activator (IV-tPA)—for the treatment of acute ischaemic stroke has been demonstrated...
Thrombolysis versus thrombectomy: Honours even between basilar occlusion treatments in CX...
Thrombolysis is considered as effective as mechanical thrombectomy for the treatment of basilar artery occlusion (BAO)—despite existing evidence on both intervention options being limited....
First-pass success in mechanical thrombectomy lowers costs in treatment of acute...
A recent Cerenovus study published in the Journal of Stroke (JOS) has found that in the treatment of acute ischaemic stroke, achieving complete or near...
Complete reperfusion may not offer better outcomes than near-complete reperfusion
Ching-Jen Chen discusses his recent publication in the BMJ entitled, “Is a picture-perfect thrombectomy necessary in acute ischaemic stroke?”
Whether imaging findings translate into outcomes...
Novel tandem stent thrombectomy technique a “safe and effective” rescue treatment
A novel tandem stent thrombectomy technique “seems to be a safe and effective” rescue treatment for acute large vessel occlusion (LVO) that is resistant...
Thrombectomy proved efficacious in Latin America as the final results of...
After receiving a standing ovation when presented at the European Stroke Organisation Conference (ESOC; 22–24 May, Milan, Italy) last year, the final results of...
phenox announces European launch of its new thrombectomy devices
phenox has announced the full European launch of the pRESET 5–40 and pRESET LUX 4–20 thrombectomy devices after receiving CE mark approval last year....
Direct mechanical thrombectomy alone deemed non-inferior to its combination with alteplase
Investigators of the DIRECT-MT trial, who evaluated Chinese patients with acute ischaemic stroke from large-vessel occlusion, concluded that endovascular thrombectomy alone was non-inferior in...
ISC News: Non-inferiority for direct mechanical thrombectomy “could not be proven”
Skipping IV thrombolysis and using mechanical clot removal alone for stroke was not shown to be non-inferior compared to the combination of both treatments,...
General anaesthesia associated with better clinical outcome compared to procedural sedation...
In a recently published systematic review and meta-analysis, the use of protocol-based general anaesthesia (GA) in acute ischaemic stroke patients undergoing thrombectomy was significantly...
Patrick Brouwer
Patrick Brouwer speaks to NeuroNews about what he considers to be the most important developments in the neurointerventional field to date. As president of...
The 1st International Distal Thrombectomy Summit called for a need to...
The 1st International Distal Thrombectomy Summit took place in North Italy, 14–15 June, 2019. According to a press release, the purpose of the meeting...
Poll favours interventional radiologists to perform mechanical thrombectomy in lieu of...
According to a BIBA MedTech survey, 52% of neurointerventionalists believe that they are the only specialists who have the relevant skills and experience to perform...
Endovascular thrombectomy decision-making: Practice area and physician experience among top factors...
A survey investigating the factors associated with the decision-making for endovascular thrombectomy (EVT) procedures found that such decisions differed significantly between regions and specialities...
APERIO hybrid thrombectomy device receives CE mark approval
Acandis GmbH announces that it has received European CE mark approval for its APERIO hybrid thrombectomy device. APERIO is intended for restoration of the...
The “overwhelming” efficacy of mechanical thrombectomy pursues in developing countries: RESILIENT,...
The final results of the first thrombectomy trial in a developing country convey the “overwhelming efficacy of mechanical thrombectomy”. Given that 35% of the...
Vesalio obtains additional CE approval for new products with NeVa clinical...
Vesalio has announced that it has obtained its second CE approval spanning multiple new NeVa product designs and technology. The new generation NeVa devices...
Reperfusion promotes favourable outcomes in ischaemic stroke patients with ASPECTS 0–5...
In a subgroup of acute ischaemic stroke patients presenting with Alberta stroke program early CT score (ASPECTS) 0–5, who were treated with mechanical thrombectomy,...
The efficacy of endovascular stroke therapy outside of specialised centres needs...
Real-world data investigating patient outcome after endovascular stroke therapy in high versus low volume centres finds a 30% increase in the likelihood of a...
First pass effect…always the goal!
Ischaemic stroke is as quick as it is destructive; minutes, even seconds can be the difference between patients returning to a healthy life or a hindered one....
